In a significant announcement, Veeva has communicated its decision not to renew its partnership agreement with SalesForce (SFdC) effective September 2025. This development prompts businesses to consider the implications and chart a course forward. While customers are assured the use of SFdC systems until 2030, Veeva has advised transitioning to their flagship solution, Veeva Vault.
Veeva’s decision not to renew its partnership with SFdC, effective September 2025, holds considerable implications for pharmaceutical industry stakeholders. This document endeavors to offer an impartial examination of the repercussions, challenges, and prospects entailed in this transition.
While customers retain access to SFdC systems until 2030, Veeva is strongly advocating for a transition to their flagship platform, Veeva Vault. This shift, however, comes with its own set of considerations.
The termination of the SFdC partnership implies that, post September 2025, Veeva customers may face restricted access to SFdC updates. Additionally, support for the legacy system is expected to wane as resources are reallocated towards the conversion to Veeva Vault. Accenture has been designated as Veeva’s preferred integration partner, indicating a strategic alignment to facilitate a seamless transition for customers.
Zensights has authored a Whitepaper on the topic, which can be accessed below.